A Phase Ii Randomized Study Of Lapatinib In Combination With Capecitabine, Vinorelbine Or Gemcitabine As First Or Second Line-Therapy In Patients With Her2 Positive Metastatic Breast Cancer Progressing After Taxane (Lacog 0801)
CANCER RESEARCH(2013)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要